JPS60172925A - 胆石溶解剤 - Google Patents

胆石溶解剤

Info

Publication number
JPS60172925A
JPS60172925A JP59028170A JP2817084A JPS60172925A JP S60172925 A JPS60172925 A JP S60172925A JP 59028170 A JP59028170 A JP 59028170A JP 2817084 A JP2817084 A JP 2817084A JP S60172925 A JPS60172925 A JP S60172925A
Authority
JP
Japan
Prior art keywords
oil
acid
fatty acid
gallstone
dissolving agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59028170A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0466847B2 (en:Method
Inventor
Kenji Hara
健次 原
Shigenobu Okada
岡田　穣伸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP59028170A priority Critical patent/JPS60172925A/ja
Publication of JPS60172925A publication Critical patent/JPS60172925A/ja
Publication of JPH0466847B2 publication Critical patent/JPH0466847B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP59028170A 1984-02-17 1984-02-17 胆石溶解剤 Granted JPS60172925A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59028170A JPS60172925A (ja) 1984-02-17 1984-02-17 胆石溶解剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59028170A JPS60172925A (ja) 1984-02-17 1984-02-17 胆石溶解剤

Publications (2)

Publication Number Publication Date
JPS60172925A true JPS60172925A (ja) 1985-09-06
JPH0466847B2 JPH0466847B2 (en:Method) 1992-10-26

Family

ID=12241262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59028170A Granted JPS60172925A (ja) 1984-02-17 1984-02-17 胆石溶解剤

Country Status (1)

Country Link
JP (1) JPS60172925A (en:Method)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004513077A (ja) * 2000-07-28 2004-04-30 シユタイガーバルト・アルツナイミツテルベルク・ゲーエムベーハー 血管保護作用及び抗酸化作用を有する製剤及びその使用
WO2009060452A3 (en) * 2007-11-08 2009-08-06 Galmed Int Ltd Methods and compositions for treating biliary cholesterol crystallization and related conditions
CN105288344A (zh) * 2015-11-24 2016-02-03 江崇礼 一种用于治疗肝胆结石的中药组合物及其应用
JP2018505158A (ja) * 2015-01-07 2018-02-22 ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ、アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ ネイビーＧｏｖｅｒｎｍｅｎｔ Ｏｆ Ｔｈｅ Ｕｎｉｔｅｄ Ｓｔａｔｅｓ Ｏｆ Ａｍｅｒｉｃａ， Ａｓ Ｒｅｐｒｅｓｅｎｔｅｄ Ｂｙ Ｔｈｅ Ｓｅｃｒｅｔａｒｙ Ｏｆ Ｔｈｅ Ｎａｖｙ 代謝症候群の診断および処置のための組成物および方法
US10792266B2 (en) 2017-10-23 2020-10-06 Epitracker, Inc. Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
US11992473B2 (en) 2018-05-23 2024-05-28 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
US12370166B2 (en) 2021-11-03 2025-07-29 Epitracker, Inc. Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity
US12427179B2 (en) 2019-01-09 2025-09-30 Epitracker, Inc. Compositions and methods for diagnosis and treatment of neurodegenerative diseases

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179735C (zh) * 2001-10-29 2004-12-15 江苏康缘药业股份有限公司 一种治疗肝胆结石的溶石性药物及制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4892519A (en:Method) * 1972-03-11 1973-11-30
JPS53104718A (en) * 1977-02-23 1978-09-12 Fuarumatsuoiteitsushiyu Fuabur Production of biliary calculus solubulizing agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4892519A (en:Method) * 1972-03-11 1973-11-30
JPS53104718A (en) * 1977-02-23 1978-09-12 Fuarumatsuoiteitsushiyu Fuabur Production of biliary calculus solubulizing agent

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004513077A (ja) * 2000-07-28 2004-04-30 シユタイガーバルト・アルツナイミツテルベルク・ゲーエムベーハー 血管保護作用及び抗酸化作用を有する製剤及びその使用
WO2009060452A3 (en) * 2007-11-08 2009-08-06 Galmed Int Ltd Methods and compositions for treating biliary cholesterol crystallization and related conditions
JP2018505158A (ja) * 2015-01-07 2018-02-22 ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ、アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ ネイビーＧｏｖｅｒｎｍｅｎｔ Ｏｆ Ｔｈｅ Ｕｎｉｔｅｄ Ｓｔａｔｅｓ Ｏｆ Ａｍｅｒｉｃａ， Ａｓ Ｒｅｐｒｅｓｅｎｔｅｄ Ｂｙ Ｔｈｅ Ｓｅｃｒｅｔａｒｙ Ｏｆ Ｔｈｅ Ｎａｖｙ 代謝症候群の診断および処置のための組成物および方法
CN105288344A (zh) * 2015-11-24 2016-02-03 江崇礼 一种用于治疗肝胆结石的中药组合物及其应用
US10792266B2 (en) 2017-10-23 2020-10-06 Epitracker, Inc. Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
US11951088B2 (en) 2017-10-23 2024-04-09 Epitracker, Inc. Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
US11992473B2 (en) 2018-05-23 2024-05-28 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
US12427179B2 (en) 2019-01-09 2025-09-30 Epitracker, Inc. Compositions and methods for diagnosis and treatment of neurodegenerative diseases
US12370166B2 (en) 2021-11-03 2025-07-29 Epitracker, Inc. Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity

Also Published As

Publication number Publication date
JPH0466847B2 (en:Method) 1992-10-26

Similar Documents

Publication Publication Date Title
RU2560677C2 (ru) Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
JP4526598B2 (ja) 乳化型外用剤およびその製造方法
RU2559084C2 (ru) Фармацевтическая композиция, включающая растворяющую смесь и производное или аналог витамина d
US9629872B2 (en) Sodium thiosulphate for the treatment of ectopic calcifications
TW200409646A (en) Topical composition
JP2017214407A (ja) スクリーンフォーマー用の外用組成物
MX2010007410A (es) Formulacion de imiquimod.
JPS60172925A (ja) 胆石溶解剤
FR2496459A1 (fr) Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
JP3802105B2 (ja) ジクロフェナクナトリウム含有乳化外用剤
US5472705A (en) Pharmaceutical composition containing esters of ω-3 polyunsaturated acids and their use in the topical treatment of morbid affections
JP7198625B2 (ja) 水性外用医薬組成物
WO2021061913A1 (en) Diclofenac sodium topical solution
US4767783A (en) Gallstone dissolver
US20010033847A1 (en) Dermatologic preparation
JPS60172922A (ja) 胆石溶解剤
WO2017175810A1 (ja) 医薬組成物
JPS60172921A (ja) 胆石溶解剤
JP7558545B1 (ja) ロキソプロフェン含有皮膚外用剤
JPS60172920A (ja) 胆石溶解剤
TW201116274A (en) Pharmaceutical composition
JP7226957B2 (ja) 外用医薬組成物
JPS6042324A (ja) 胆石溶解剤
JP2021080170A (ja) 非水系貼付剤
JPH05117141A (ja) 副腎エキス含有消炎鎮痛ゲル剤